enVVeno Medical Corporation

NASDAQ:NVNO

5.19 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Omzet 000.824000000000000.0310000000.0310.030.0420.0830.0310.1750.0280.0390.180.3050.2950.0930.0930
Kosten van de omzet 0.1360.1410.1340.1380.1380.1360.130.1330.1330.1290.1220.120.1080.104000000000.9460.4250.2800.0980.13300.1890.2120.3970.1010.1010
Brutowinst -0.136-0.1410.69-0.138-0.138-0.136-0.13-0.133-0.133-0.129-0.122-0.12-0.108-0.1040.0310000000.031-0.915-0.383-0.1970.0310.077-0.1050.039-0.0080.093-0.101-0.008-0.0080
Brutowinstmarge 000.8370000000000010000001-30.039-9.191-2.36410.44-3.7681-0.0470.305-0.343-0.085-0.0850
Onderzoek- en ontwikkelingskosten 2.8253.0522.9812.7984.2143.5952.7972.4923.0731.5521.7821.2251.091.6322.2770.7580.7060.5110.7880.6770.4280.3130.2930.4250.280.240.3490.0430.1850.07300000
Algemene en administratieve kosten 00000000000000000000000000000000000
Verkoop- en marketingkosten 00000000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 2.4932.313.1632.5512.63.2023.6633.6593.9133.7837.2111.4821.2961.1761.8811.1640.840.9980.9221.1571.5321.3011.2171.1052.9151.2471.6571.6641.0861.051.2280.9591.2241.2240.458
Overige kosten 0000000000000.0010.032000000000000000000000
Bedrijfskosten 5.3185.3626.1445.3496.8146.7976.466.1516.9865.3358.9922.7072.3852.8084.1581.9221.5461.5091.711.8341.961.6141.511.5293.1951.4882.0061.7071.2711.1221.2280.9591.461.460.583
Bedrijfsresultaat -5.454-5.503-6.278-5.349-6.814-6.797-6.46-6.151-6.986-5.335-8.992-2.707-2.385-2.808-4.158-1.922-1.546-1.509-2.299-1.834-1.96-1.582-1.799-1.488-3.112-1.456-1.929-1.812-1.232-1.131-1.136-1.06-1.232-1.232-0.584
Bedrijfsresultaat ratio 00-7.61900000000000-133.099000000-50.646-59.055-35.708-37.328-46.884-11.013-64.999-31.746-6.271-3.725-3.588-13.274-13.2730
Totaal overige inkomsten en kosten netto 0.4980.5110.6290.3040.3010.4050.280.054-0.1130.0050.0050.3130.0010.032-0.216-0.053-0.0810.3460.0080.0190.0140.009-0.320.0190.1841.4890.6240.0040.022-0.024-0.397-0.002-0.254-0.254-0.041
Inkomen voor belasting -4.956-4.992-5.649-5.001-6.474-6.392-6.18-6.097-7.062-5.33-8.988-2.389-2.378-2.773-4.374-1.975-1.627-1.16-2.291-1.815-1.946-1.574-1.782-1.468-5.045-4.747-3.124-2.255-1.249-1.164-1.54-1.076-1.486-1.486-0.624
Inkomen voor belasting ratio 00-6.85600000000000-139.999000000-50.371-58.487-35.24-60.523-152.824-17.839-80.878-32.188-6.454-5.052-3.643-16.013-16.0120
Belastingkosten 00.0981.453-0.348-0.34-0.765-0.474-0.0330.07600-0.317-0.007-0.003-00.0520.081-0.0030.5970.0190.0140.009-0.01700.1120.210.1090.4470.0160.0090.0070.0140.0750.0750.004
Nettowinst -4.956-4.992-5.649-5.001-6.474-5.627-5.706-6.064-7.062-5.33-8.988-2.389-2.378-2.773-4.374-1.975-1.627-1.16-2.291-1.815-1.946-1.574-1.782-1.468-5.045-4.747-3.124-2.255-1.249-1.164-1.54-1.076-1.561-1.561-0.628
Nettowinstmarge 00-6.85600000000000-139.999000000-50.371-58.487-35.24-60.523-152.824-17.839-80.878-32.188-6.454-5.052-3.643-16.819-16.8190
WPA (Winst Per Aandeel) -0.31-0.31-0.42-0.45-0.58-0.5-0.6-0.54-0.63-0.47-0.8-0.26-0.28-0.48-1.72-1.37-1.89-1.57-3.19-2.53-3.28-3.21-3.79-3.13-16.21-11.69-8.06-5.82-2.85-2.65-3.51-2.45-6.5-6.5-2.62
Verwaterde WPA -0.31-0.31-0.42-0.45-0.58-0.5-0.6-0.54-0.63-0.47-0.8-0.26-0.28-0.48-1.72-1.37-1.89-1.57-3.19-2.53-3.28-3.21-3.79-3.13-16.21-11.69-8.06-5.82-2.85-2.65-3.51-2.45-6.5-6.5-2.62
EBITDA -5.318-5.362-6.144-5.515-6.977-7.021-6.566-5.997-6.74-5.206-8.871-2.899-2.278-2.705-4.062-1.771-1.361-1.422-1.597-1.711-1.85-1.482-1.446-1.454-5.084-5.993-3.606-1.779-1.219-1.094-1.095-1.02-1.197-1.197-0.554
EBITDA ratio 00-7.45600000000000-130.027000000-47.447-47.458-34.906-60.987-192.918-20.589-63.814-31.423-6.067-3.591-3.451-12.898-12.8980